An anthrone-based Kv7.2/7.3 channel blocker with improved properties for the investigation of psychiatric and neurodegenerative disorders.

Porter JD, Vivas O, Weaver CD, Alsafran A, DiMilo E, Arnold LA, Dickson EJ, Dockendorff C
Bioorg Med Chem Lett. 2019 29 (23): 126681

PMID: 31668424 · PMCID: PMC6858848 · DOI:10.1016/j.bmcl.2019.126681

MeSH Terms (9)

Anthracenes Dose-Response Relationship, Drug KCNQ2 Potassium Channel KCNQ3 Potassium Channel Mental Disorders Molecular Structure Neurodegenerative Diseases Potassium Channel Blockers Structure-Activity Relationship

Connections (1)

This publication is referenced by other Labnodes entities: